Diastolic heart failure is characterized by increased resistance to diastolic filling of one or both cardiac ventricles. Although some degree of diastolic failure exists in most patients presenting clinically with heart failure, a substantial subset of patients have relatively pure diastolic heart failure with normal systolic function. Diastolic heart failure can be due to structural abnormalities that increase resistance to ventricular inflow, and these structural abnormalities can be extramyocardial (e.g., constrictive pericarditis and mitral stenosis) or intramyocardial (e.g., fibrosis and amyloidosis). In addition to structural abnormalities, physiological derangement of myocardial inactivation and relaxation can contribute importantly to diastolic dysfunction in patients with heart failure. There is mounting evidence that advanced myocardial hypertrophy is associated with increased resistance to ventricular diastolic inflow due to both structural alteration (increased wall thickness and altered collagen matrix) and impaired diastolic relaxation of the hypertrophied myocardium. Physiological mechanisms for impaired relaxation in advanced hypertrophy remain controversial but can include disordered function of myocardial sarcoplasmic reticulum, subendocardial ischemia, and altered adenylate cyclase function. Diastolic dysfunction can play an important role in the genesis of flash pulmonary edema seen in patients with ischemic heart disease because myocardial ischemia is associated with a decline in relaxation rate, increased resistance to early diastolic filling, and in some cases, a striking upward shift in the left ventricular diastolic pressure-volume relation. Finally, impaired myocyte calcium handling has been reported to occur in a variety of conditions (advanced human heart failure, experimental myocardial ischemia, and hypertrophic cardiomyopathy) characterized by diastolic dysfunction and might play a unifying role as a basic mechanism for diastolic heart failure. (Circulation 1990;81(suppl III):III-1-III-7) T raditional definitions of heart failure have emphasized the heart's systolic function by defining heart failure in terms of insufficiency of cardiac output relative to metabolic needs of the body. In fact, the heart has both systolic and diastolic functions, and heart failure exists when the heart fails in one or both of its primary functions: 1) during diastole, to receive blood into the cardiac ventricles at low pressure and 2) during systole, to propel blood into the great vessels under increased pressure. In this context, heart failure can exist despite a cardiac output that is normal both at rest and exercise. Table 1 lists a variety of conditions associated with heart failure due to diastolic dysfunction.
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In several of these conditions, systolic ejection is vigorous, but the ventricles cannot receive blood at their normal low filling pressures because of obstruction or resistance to filling. Thus, conditions 1-4 in Table 1 can be associated with completely normal myocardial contractile function, but the patient will exhibit classic congestive heart failure due to increased diastolic filling pressures for one or both ventricles. As an illustrative example, the patient whose data are presented in Table 2 is a 39-year-old woman with a history of rheumatic fever in childhood who presented with increasing dyspnea on exertion. Echocardiography suggested only mild-to-moderate mitral stenosis. Hemodynamic evaluation demonstrated a normal cardiac output at rest with a small resting diastolic gradient across the mitral valve. Left atrial pressure at rest was nearly normal at 11 mm Hg. With 6 minutes of supine bicycle exercise, her left atrial pressure rose to 33 mm Hg with substantial increases in forward cardiac output and mitral valve gradient. Thus, in this case, the left heart was able to fulfill its systolic function well, both at rest and during exercise, but failed during exercise in its diastolic function of receiving blood into the left ventricle (LV) at low pressure. The patient's dyspnea on exertion can thus be considered an instance of diastolic heart failure.
Most attention in the area of heart failure research has been devoted to understanding the pathophysiology and biochemical and structural alterations that account for the systolic and diastolic myocardial failure seen with conditions 5-7 in Table 1 . As seen in Figure 1 , myocardial dysfunction as a basis for congestive heart failure can be described hemodynamically in terms of the ventricular pressure-volume diagram. Pure systolic failure (Figure 1 , upper panel) is associated with a depression in the end-systolic pressure-volume relation; as a result, ventricular dilatation occurs along a normal diastolic pressurevolume relation, thereby using the Frank-Starling relation to restore stroke volume and cardiac output toward normal. This preservation of cardiac output, however, occurs at the cost of ventricular dilatation and increased diastolic pressure. In contrast, pure diastolic failure (Figure 1 , middle panel) is associated with preservation of the end-systolic pressure-volume relation but distortion of the diastolic relation, so that diastolic pressure is higher at any given volume. Thus, stroke volume and cardiac output are maintained but again at the cost of an increased diastolic filling pressure. Commonly, systolic and diastolic failure coexist (Figure 1 , lower panel), especially in dilated cardiomyopathy or the advanced heart failure seen in patients who have had multiple myocardial infarctions. An increasing number of patients,' however, are being recognized as having congestive heart failure solely on the basis of diastolic dysfunction.
Factors That Influence Ventricular Distensibility
Ventricular disteensibility is influenced by a variety of factors that can be considered either extrinsic or intrinsic to the ventricular chambers ( Table 3 ). Table 3 , a variety of factors influence ventricular distensibility and can contribute to the elevations in diastolic pressure commonly seen in heart failure. Of much recent interest is the concept of active elasticity of the ventricular wall due to residual cross-bridge activation. Slowing of the relaxation process is seen in myocardial ischemia14"16"18-22 as well as in cardiac hypertrophy24 and failure.17 Slowing of relaxation blunts early diastolic filling, which is usually quite rapid. With the blunting of early diastolic relaxation, there is increased dependence on late diastolic filling to achieve adequate diastolic sarcomere stretch, so that atrial contraction becomes even more important than in the normal heart. Thus, patients with impaired myocardial relaxation from either myocardial ischemia or advanced hypertrophy tolerate loss of the atrial "kick" poorly, often developing acute congestive heart failure. Slowing of diastolic relaxation also lessens the coronary pressure gradient for perfusion of the subendocardium by prolonging the elevation of diastolic pressure in the ventricle. Seventy to eighty percent of coronary blood flow occurs during diastole in the normal heart although this percentage is reduced during tachycardia. The time available for diastolic coronary filling is impeded further by slowed myocardial relaxation because myocardial contraction persisting into early diastole compresses intramyocardial coronary vessels. Although it is well established that slowing of myocardial relaxation occurs during ischemia and in the setting of advanced myocardial hypertrophy, the occurrence of incomplete relaxation (affecting early, mid-, and end-diastolic distensibility) is controversial. Of interest in this regard, there is extensive evidence that the LV diastolic pressurevolume relation commonly shifts upward in patients with angina pectoris induced by exercise25 or pacing tachycardia,'1522'26'27 with increases in early, mid-, and end-diastolic pressure relative to volume ( Figure 2 ). Whether this altered diastolic distensibility is due to incompleteness of the relaxation process is hard to determine in clinical studies; however, a large body of animal experimentation supports both slowed and incomplete relaxation as characterizing acute demand ischemia.'9-21 Of interest, the upward shift (impaired diastolic distensibility) in LV diastolic pressure relative to volume seen with demand ischemia or with hypoxia6 is usually not seen with primary ischemia due to coronary occlusion.6,28
As seen in
Heart Failure and Hypertrophy Myocardial overload results in hypertrophy, which develops in a pattern characteristic for the inciting stress.29 Although hypertrophy has the beneficial effect of restoring wall stress toward normal and thereby improving cardiac performance, the increased muscle mass predisposes the hypertrophied ventricle to myocardial ischemia. Furthermore, a late transition from hypertrophy to failure often occurs although its biochemical and structural basis is still obscure. Although this transition to failure is clearly associated with depression of systolic performance, changes in diastolic relaxation and distensibility occur as well. Ventricular Remodeling and Heart Failure In patients who have had myocardial infarction, ventricular hypertrophy serves as a compensatory mechanism whereby noninfarcted segments of the ventricle undergo regional hypertrophy and take over the function no longer performed by the infarcted segment,3031 which is replaced with scar tissue. The changes in regional wall stress associated with infarction32 and the subsequent regional hypertrophy process result in extensive remodeling of the left ventricle.3031'33 The remodeling process resembles volume-overload hypertrophy for the noninfarcted segment, and there is increasing evidence that a late transition from hypertrophy to failure occurs in some patients who have had large myocardial infarctions, even in the absence of further ischemic events.3033 Thus, heart failure in the patient with coronary artery disease can represent a process similar to the late heart failure seen in patients with long-standing ventricular overload from a variety of hemodynamic causes (e.g., chronic mitral or aortic regurgitation). In addition to altered systolic and diastolic function of the hypertrophied segment, scar formation in the infarcted segment plays an important role in decreasing LV distensibility. The stiff scar tissue often results in a very large "a" wave seen in the pulmonary capillary wedge and LV pressure tracings. The sequence of events that can occur in the late heart failure seen after myocardial infarction are illustrated in Figure 3 . Although remodeling with regional hypertrophy can be sufficient in itself to cause late heart failure in some patients after myo- cardial infarction, myocardial ischemia of the hypertrophied segment can contribute to heart failure in individuals with additional coronary lesions. Thus, impaired relaxation that occurs in the hypertrophied myocardium34 can be exacerbated by decreased coronary perfusion and regional ischemia.
Cellular Mechanisms of Diastolic Dysfunction
Much interest has centered around the cellular mechanisms of contractile dysfunction in congestive heart failure. Physiological adaptation of the heart to pathological overloading is associated with a variety of protein-isoform switches due to altered gene regulation and transcription.35-37 At the present time, there is strong evidence that myosin isozyme transformations occur as part of the response to hemodynamic overload in the hearts of small animals (e.g., rat) and are associated with depression of myosin ATPase activity and decreased velocity of myofiber shortening. Large animals (including humans), however, do not appear to exhibit such myosin isozyme shifts in response to hemodynamic overload. Depression of sarcoplasmic reticular calcium ATPase has been reported in animal and human myocardium with hypertrophy and failure.37-39 Findings by Gwathmey et a140 have shown that intracellular calcium handling is disordered in myocytes from patients with end-stage congestive heart failure. The abnormalities of myocyte calcium handling are such that calcium release occurs normally, but calcium disappearance from the cytosol is delayed. Thus, diastolic calcium is elevated in myocardial preparations from patients with end-stage heart failure, and this increase becomes exaggerated under conditions of increased calcium in the external bathing medium or increased rate of stimulation. The underlying mechanisms for this abnormal diastolic calcium configuration are unknown but might be related to dysfunctional calcium uptake by sarcoplasmic reticulum. A deficiency in cyclic adenosine monophosphate (AMP) has been postulated to play a role in the physiological derangements seen in heart muscle from patients with end-stage heart failure.41 Cyclic AMP plays a critical role in regulating a variety of intracellular functions. In particular, this second messenger enhances diastolic relaxation by activating phospholamban, the regulatory protein for the calcium ATPase of sarcoplasmic reticulum (Figure 4) . A deficiency of cyclic AMP could result from decreased /3-adrenergic stimulation due to down-regulation of ,B-receptors in heart failure4243 or could represent altered regulation of adenylate cyclase. In this regard, a potentially important cause of deficient myocardial cyclic AMP might be abnormal G protein expression, as reported by Feldman et al. 44 These investigators reported an increase in the inhibitory component of the G protein complex, Gi, in failing human myocardium. In general, agents that increase cyclic AMP, such as milrinone (an inhibitor of phosphodiesterase) and forskolin (a direct activator of adenylate cyclase), can improve diastolic function in clinical4546 and experimental41,42 studies of congestive heart failure. One study,47 however, reported that improvement of LV diastolic function with a phosphodiesterase inhibitor (enoximone) can be mediated primarily by vasodilator rather than lusitropic action.
Cellular mechanisms responsible for the heart failure associated with acute myocardial ischemia or hypoxia have been the subject of intense investigation for many years. In studying diastolic function during ischemia, it is important to distinguish the very different functional effects of supply ischemia and demand ischemia.6 Supply ischemia, induced by sud-den cessation of coronary blood flow, induces a very rapid loss of contractile function; the time course of this loss of contractility is too rapid to be accounted for by decreased high-energy phosphate synthesis. Early in the course of supply ischemia, diastolic dysfunction is mild and is greatly overshadowed by the systolic contractile dysfunction. Loss of coronary turgor and myofiber stretch, together with depression of calcium-activated force by inorganic phosphate and hydrogen ion accumulation, all appear to contribute to the contractile dysfunction of supply ischemia while simultaneously protecting against diastolic dysfunction. In demand ischemia such as produced by pacing tachycardia or exercise in the presence of restricted coronary blood flow, contractile function is relatively well preserved while impaired diastolic relaxation is prominent. A very similar functional response is seen early in the course of myocardial hypoxia with continued coronary perfusion to prevent accumulation of metabolites. Highenergy phosphate depletion occurs in this setting48 but is modest. Evidence from studies by Lorell et al4950 using ouabain and isoproterenol strongly suggest a role for altered intracellular calcium in demand ischemia. Increased intracellular free calcium has been demonstrated to occur promptly during myocardial ischemia.5152 Furthermore, recent evidence from Morgan's laboratory, studying intracellular calcium simultaneous with LV pressure in the isovolumic ferret LV, indicates that a rise in diastolic calcium is likely responsible for the impaired diastolic relaxation seen in this setting. 53 
Clinical Implications
Diastolic dysfunction plays a contributory role in most patients with congestive heart failure and a dominant role in some patients. When diastolic dysfunction occurs, it can be due to mechanical factors (e.g., pericardial constriction, myocardial fibrosis, or other mechanical problems listed in Tables 1 and 3 ). An increasing body of evidence, however, indicates that biochemical alterations within the myocyte can play a critical role in causing diastolic dysfunction. Although these changes can be immediate biochemical consequences of ischemia or hypoxia (e.g., increase in [Ca2+]j and decreases in adenosine triphosphate and creatine phosphate), altered genetic expression with isoform switches of critical proteins are likely to explain many of the current mysteries in heart failure research. A recurrent theme in many disease states that lead to congestive heart failure is the early development of hypertrophy with a late transition from hypertrophy to myocardial failure. Again, it appears likely that molecular biology research will unravel the mysteries associated with this poorly understood transition from hypertrophy to failure.
